Your browser doesn't support javascript.
loading
Significant weight gain in CLL patients treated with Ibrutinib: A potentially deleterious consequence of therapy.
Williams, AnnaLynn M; Baran, Andrea M; Schaffer, Mahlon; Bushart, Jocelyn; Rich, Lynn; Moore, Jeremiah; Barr, Paul M; Zent, Clive S.
Afiliação
  • Williams AM; University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, New York.
  • Baran AM; University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, New York.
  • Schaffer M; University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, New York.
  • Bushart J; University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, New York.
  • Rich L; University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, New York.
  • Moore J; University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, New York.
  • Barr PM; University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, New York.
  • Zent CS; University of Rochester Medical Center, James P. Wilmot Cancer Institute, Rochester, New York.
Am J Hematol ; 95(1): E16-E18, 2020 01.
Article em En | MEDLINE | ID: mdl-31621100

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Leucemia Linfocítica Crônica de Células B / Aumento de Peso Tipo de estudo: Observational_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Leucemia Linfocítica Crônica de Células B / Aumento de Peso Tipo de estudo: Observational_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2020 Tipo de documento: Article